Core Insights - Fangzhou Inc. has launched its proprietary "XingShi" Large Language Model (XS LLM) aimed at improving chronic disease management through enhanced service efficiency and personalization [1][4] - The XS LLM integrates multimodal capabilities including image and speech recognition, natural language processing, and large-scale medical knowledge storage, supporting five domain-specific intelligent agents [2] - The model serves as the core digital brain of Fangzhou's platform, powering five AI-enabled applications that facilitate real-time interventions in medication guidance, patient education, and diagnostic assistance [3] Company Overview - Fangzhou Inc. is a leading online chronic disease management platform in China, with 52.8 million registered users and 229,000 physicians as of June 30, 2025 [5] - The company specializes in tailored medical care and AI-enabled precision medicine solutions, reflecting its commitment to scalable and accessible healthcare delivery [4][5]
Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management